Sabrina Ronen, PhD, UCSF Brain Tumor Center

Sabrina Ronen, PhD

Principal Investigator

Research Interests: magnetic resonance spectroscopy, metabolic imaging, preclinical cancer models

Dr. Ronen’s Laboratory focuses on developing and mechanistically validating robust non-invasive translatable magnetic resonance (MR)-based biomarkers that can be used to monitor oncogenic transformation and response to therapy. Dr. Ronen has ongoing research projects on probing the metabolism of brain tumors, monitoring PI3K signaling, detecting the mutational status of isocitrate dehydrogenase, and assessing response to emerging therapeutic approaches for brain tumors.

Ronen Lab Website >



Education and Training

1981: BSc, Chemistry/Biochemistry, Hebrew University, Israel
1986: MS, Chemistry, San Jose State University
1991: PhD, Chemical Physics, Weizmann Institute of Science, Israel
1992-1994: INSERM Poste Vert Visiting Researcher, Institut Curie, France
1994-1996: British Heart Foundation Fellow, Harefield Hospital Nephrology, UK
1996-2003: ICR Fellow and Leader, Pre-Clinical Cellular Processes Team, CRUK Clinical Magnetic Resonance Research Group, Institute of Cancer Research Sutton, UK

Academic Positions

2004-2007: Associate Professor, Experimental Diagnostic Imaging, University of Texas, MD Anderson Cancer Center
2007-2012: Associate Professor, Department of Radiology, UCSF
2012-Present: Professor, Department of Radiology, UCSF
2016-2018: Associate Director Precision Imaging of Cancer and Therapy (PICT) program
2017-Present: Co-Director, Neuroimaging Research Interest Group, UCSF
2018-Present: Director Precision Imaging of Cancer and Therapy (PICT) program

Selected Awards

2016: Named Senior Fellow, International Society of Magnetic Resonance in Medicine
2015-2018: Board of Trustees, World Molecular Imaging Society
2013: Named Distinguished Investigator, Academy of Radiology Research